arrow
M

Masato Okada

University of Osaka
H指数:23
被引数:1,747

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ALID score for treatment-effect heterogeneity of adjunctive low-voltage area ablation in persistent atrial fibrillation: A post hoc analysis of SUPPRESS-AF

低电压区域消融作为附加治疗在持续性心房颤动中治疗效果异质性的ALID评分:SUPPRESS-AF研究的回顾性分析

2026-07-010
OAAI
Prognostic Implications of Heart Rate Score and Its Temporal Change in Left Ventricular Systolic Dysfunction: Insights From the HINODE Study

左心室收缩功能不全中心率评分及其时间变化的预后意义:HINODE研究的见解

2025-12-010
OAAI
Cardiothoracic ratio as a prognostic marker in heart failure with preserved ejection fraction

心胸比率作为射血分数保留的心力衰竭的预后标志物

2025-09-140
PRE
Impact of renal function on the efficacy of low-voltage area ablation after pulmonary vein isolation: a sub-analysis of the SUPPRESS-AF trial

肾功能对肺静脉隔离后低电压区域消融疗效的影响:SUPPRESS-AF试验的亚组分析

2025-09-010
OAAI
Risk factors of late arrhythmia recurrences over 12 months after catheter ablation of atrial fibrillation: Insight into atrial cardiomyopathy

房颤导管消融术后12个月以上晚期心律失常复发的危险因素:对心房心肌病的见解

2024-12-170
PRE
Estimated Plasma Volume Status Reflected Changes In Hemodynamic Parameters On Echocardiogram After Treatment In Patients With Heart Failure With Preserved Ejection Fraction

估计的血浆容量状态反映了射血分数保留的心力衰竭患者治疗后超声心动图血流动力学参数的变化

2024-11-120
PRE
Evolution of Tricuspid Regurgitation and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from the PURSUIT-HFpEF Registry

三尖瓣反流演变及临床结局在射血分数保留的心力衰竭患者中的研究:PURSUIT-HFpEF注册研究的启示

2024-11-120
PRE
A Novel Echocardiography Risk Score Predicted Mortality In Patients With Heart Failure With Preserved Ejection Fraction.

一种新型超声心动图风险评分可预测射血分数保留的心力衰竭患者的死亡率。

2024-11-120
PRE
Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial

持续性房颤伴二尖瓣反流患者的广泛消融: 来自earnest-pvi前瞻性随机试验的见解

2024-09-011
OAAI
Appropriate Selection of Substrate Ablation for Persistent Atrial Fibrillation Using Intraprocedural Assessment
2024-06-252
OA
Duration of atrial fibrillation persistence: Implications for recurrence risk after catheter ablation and efficacy of additional substrate ablation
2024-06-013
PRE